i
POLYSUBSTANCE USE DURING PREGNANCY AND THE BENEFITS OF UNIVERSAL VERBAL SCREENING
-
JANUARY 2024
Details:
-
Corporate Authors:
-
Description:The use of two or more substances, also known as polysubstance use, is common during pregnancy and can lead to adverse maternal and infant outcomes. This report discusses polysubstance use during pregnancy, universal verbal screening, and its benefits. ASTHO affirms the vital need for health equity in addressing polysubstance use during pregnancy. This includes building culturally competent systems that adapt healthcare delivery to meet patients’ unique needs, and using person-centered language that reduces stigma, which collectively mitigates barriers to recovery.
This publication was supported by Cooperative Agreement Number CDC-RFA-OT18-1802, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services. The mark ‘CDC’ is owned by the U.S. Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise.
polysubstance-use-during-pregnancy-and-the-benefits-of-universal-screening.pdf
-
Subjects:
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: